Because the NCSP provides a single annual FIT, FIT results were processed using only one sampling, either by qualitative or quantitative methods. For those with two or more FITs during the study period, we included only the initial FIT results. For the qualitative FIT, SD Bioline FOB kits (SD, Co., Korea), with a cutoff point of 30 ng/mL; ASAN Easy Test FOB kits (Asan Pharm, Co., Korea), with a cutoff point of 50 ng/mL; FOB test kits (Humasis, Co., Korea), with a cutoff point of 50 ng/mL; and OC-Hemocatch Light kits (Eiken Chemical, Co., Tokyo, Japan), with a cutoff point of 50 ng/mL, were applied. For the quantitative FIT, Medex HM-JACK kits (Kyowa Chemical Industry, Co., Kagawa, Japan), with a cutoff point of 30 ng/mL; Hemo Tech NS-1000 kits (Alfresa Pharma, Co., Osaka, Japan), with a cutoff point of 40 ng/mL; and OC-Sensor DIANA kits (Eiken Chemical, Co.), with cutoff point of 100 ng/mL, were used [12 (link),13 (link)].
Free full text: Click here